Clesrovimab

Clesrovimab (MK1654) 是一种抗呼吸道合胞病毒蛋白 F 人单克隆抗体,可用于预防和治疗呼吸道合胞病毒感染。

CAS号

2429913-18-6

分子式

主要靶点

Others

仅限科研使用

Cat No : CM19570

Print datasheet

Synonyms

MK-1654



产品信息

Clesrovimab (MK1654) is an anti-respiratory syncytial virus protein F human monoclonal antibody for the prevention and treatment of respiratory syncytial virus infections.

CAS号 2429913-18-6
分子式
主要靶点 Others
主要通路 其他
分子量
纯度 , 此纯度可做参考,具体纯度与批次有关系,可咨询客服
储存条件
别名 MK-1654

参考文献

1.Qiu X, et al. Development of mRNA vaccines against respiratory syncytial virus (RSV). Cytokine Growth Factor Rev. 2022 Dec;68:37-53.
2.Odumade OA, et al. Implications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on the Epidemiology of Pediatric Respiratory Syncytial Virus Infection. Clin Infect Dis. 2022 Aug 15;75(Supplement_1):S130-S135.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
=
×
×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
×
=
×
C1   V1   C2   V2